(Q44013374)

28 November 2017

title

P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype (English)

1 reference

28 November 2017

9

Arndt Hartmann

1 reference

28 November 2017

Anja Rogler

1

1 reference

28 November 2017

Michael Rogenhofer

2

1 reference

28 November 2017

Albert Borchardt

3

1 reference

28 November 2017

Jens-Claudio Lunz

4

1 reference

28 November 2017

Antje Knoell

5

1 reference

28 November 2017

Ferdinand Hofstaedter

6

1 reference

28 November 2017

Andrea Tannapfel

7

1 reference

28 November 2017

Wolf Wieland

8

1 reference

28 November 2017

Robert Stoehr

10

1 reference

28 November 2017

publication date

19 July 2011

1 reference

28 November 2017

1 reference

28 November 2017

volume

78

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

193-200

1 reference

Estimates of cancer incidence and mortality in Europe in 2008.

28 November 2017

cites work

1 reference

p53 ubiquitination: Mdm2 and beyond

21 January 2018

1 reference

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations.

21 January 2018

1 reference

Codon 72 polymorphism of the TP53 gene

21 January 2018

1 reference

Polymorphic variants in the p53 pathway.

21 January 2018

1 reference

p53 polymorphisms: cancer implications

21 January 2018

1 reference

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer

21 January 2018

1 reference

p53 gene codon 72 polymorphism but not tumor necrosis factor-alpha gene is associated with prostate cancer

21 January 2018

1 reference

The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models.

21 January 2018

1 reference

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients

21 January 2018

1 reference

CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility

21 January 2018

1 reference

Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina

21 January 2018

1 reference

Analysis of TP53 codon 72 polymorphism in HPV-positive and HPV-negative penile carcinoma

21 January 2018

1 reference

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer

21 January 2018

1 reference

Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer

21 January 2018

1 reference

Regulation of apoptosis in prostate cancer

21 January 2018

1 reference

p53-family proteins and their regulators: hubs and spokes in tumor suppression

21 January 2018

1 reference

Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: p53 with arginine at codon 72 favors apoptosis.

21 January 2018

1 reference

Molecular pathology of prostate cancer

21 January 2018

1 reference

HPV in non-gynecological tumors

21 January 2018

1 reference

Rare incidence of human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer

21 January 2018

1 reference

Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000326767

1 reference

28 November 2017

1 reference